Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | EXEL | BMRN | ||
| Company | Acceleron Pharma | Exelixis Inc | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 44.99 | 54.53 | ||
| High | 179.85 | 45.25 | 55.57 | ||
| Low | 177.06 | 43.53 | 54.31 | ||
| Latest | 178.75 | 43.61 | 54.88 | ||
| Change | -0.93 | -1.28 | +0.24 | ||
| % Change | -0.52% | -2.85% | +0.44% | ||
| Volume | 7,884,200 | 2,045,500 | 1,598,500 | ||
| 20-Day Average Volume | 1,302,050 | 2,153,725 | 1,623,010 | ||
| Previous Close | 179.68 | 44.89 | 54.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 43.61 | 55.39 | ||
| 20-Day Raw Stochastic | 84.01% | 52.68% | 34.62% | ||
| 20-Day Relative Strength | 70.12 | 50.95 | 44.58 | ||
| Weighted Alpha | +57.78 | +11.35 | -11.72 | ||
| Today's Opinion | 100% Buy | 80% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 24% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -3.00% since 04/13/26 | unch since 04/13/26 | ||
| Low | 173.17 on 11/16/21 | 43.53 on 04/20/26 | 53.79 on 04/16/26 | ||
| High | 179.94 on 11/17/21 | 46.10 on 04/15/26 | 56.05 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +5.67% since 03/20/26 | +1.39% since 03/20/26 | ||
| Low | 172.25 on 10/20/21 | 40.84 on 03/24/26 | 53.35 on 03/24/26 | ||
| High | 179.94 on 11/17/21 | 46.10 on 04/15/26 | 57.76 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -0.39% since 01/20/26 | -2.54% since 01/20/26 | ||
| Low | 120.20 on 08/20/21 | 39.71 on 03/02/26 | 53.35 on 03/24/26 | ||
| High | 189.99 on 09/29/21 | 46.10 on 04/15/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +26.26% since 10/20/25 | +3.41% since 10/20/25 | ||
| Low | 113.49 on 07/15/21 | 34.63 on 10/21/25 | 50.76 on 11/07/25 | ||
| High | 189.99 on 09/29/21 | 47.24 on 12/23/25 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,402,419 | 10,508,528 | ||
| Shares Outstanding, K | 61,156 | 254,008 | 192,323 | ||
| Annual Sales | 92,520,000 | 2,320,130,000 | 3,221,250,000 | ||
| Annual Net Income | -166,030,000 | 782,570,000 | 348,900,000 | ||
| Last Quarter Sales | 34,200,000 | 598,660,000 | 874,560,000 | ||
| Last Quarter Net Income | -70,470,000 | 244,530,000 | -46,570,000 | ||
| 60-Month Beta | 0.13 | 0.42 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 0.94 on 02/10/26 | 0.46 on 02/23/26 | ||
| Latest Earnings Date | 02/24/22 | 05/12/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.26 | 22.26 | ||